Search
Brainstorm Cell Therapeutics Inc
BCLIAdd to Watchlist
1.170USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
9.26MMarket Cap
LossP/E TTM
Brainstorm Cell Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.31
61.34%
Analyst Rating
HOLD
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its current assets were 385.00K, with a year-on-year change of -79.73.
What are the total assets of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its total assets of Brainstorm Cell Therapeutics Inc were 1.83M, with a year-on-year change of -56.46.
What are the total liabilities of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its total liabilities of Brainstorm Cell Therapeutics Inc were 9.60M, with a year-on-year change of 5.85.
What is the total equity of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its total equity of Brainstorm Cell Therapeutics Inc was -7.76M, with a year-on-year change of -59.82.
What is the net investment of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its net investment of Brainstorm Cell Therapeutics Inc was 12.00K, with a year-on-year change of -99.45.
What is the net financing of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its net financing of Brainstorm Cell Therapeutics Inc was 7.97M, with a year-on-year change of -58.02.
What is the Earnings Per Share (EPS) of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.31, with a year-on-year change of 61.34.
What is the Return on Assets (ROA) of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -384.87, with a year-on-year change of -41.69.
What is the operating profit of Brainstorm Cell Therapeutics Inc?
According to Brainstorm Cell Therapeutics Inc's FY2024 earnings report, its operating profit was -11.69M, with a year-on-year change of 45.46.